Coronary Atherectomy Devices Market Report 2026

Coronary Atherectomy Devices Market Overview

• Coronary Atherectomy Devices market size has reached to $0.23 billion in 2025 • Expected to grow to $0.37 billion in 2030 at a compound annual growth rate (CAGR) of 9.4% • Growth Driver: Increasing Prevalence Of Cardiovascular Diseases Driving Market Growth Due To Increasing Use Of Advanced Plaque-Removal Technologies • Market Trend: AngioDynamics Receives FDA Clearance for Auryon XL Radial Access Catheter to Enhance Treatment of Peripheral Arterial Disease • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Coronary Atherectomy Devices Market?

Coronary atherectomy devices are used to remove atherosclerosis from coronary blood vessels. Atherectomy devices were developed to permit drilling, grinding, or sanding of atheroma, calcium, and excess cellular material from the site of coronary occlusion or stenosis. The main products of coronary atherectomy devices are directional atherectomy devices, orbital atherectomy devices, photo-ablative atherectomy devices, rotational atherectomy devices, and others. The rotational atherectomy device is a long catheter with an oval-shaped burr that is encrusted with a microscopic diamond-embedded surface tip. The various applications involved are peripheral vascular, cardiovascular, and neurovascular that are used by end-users such as hospitals and surgical centers, ambulatory care centers, research laboratories, and academic institutes.

What Is The Coronary Atherectomy Devices Market Growth Forecast?

The coronary atherectomy devices market size is expected to see strong growth in the next few years. It will grow to $0.37 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing demand for complex coronary interventions, rising adoption of image-guided cardiovascular procedures, growing investments in cardiac care infrastructure, technological advancements in device precision, expansion of minimally invasive treatment protocols. Major trends in the forecast period include increasing use of advanced rotational atherectomy devices, rising adoption of minimally invasive coronary procedures, growing focus on calcified lesion treatment, expansion of precision-controlled atherectomy systems, enhanced integration with imaging-guided interventions.

Global Coronary Atherectomy Devices Market Segmentation

1) By Product: Directional Atherectomy Devices, Orbital Atherectomy Devices, Photo-Ablative Atherectomy Devices, Rotational Atherectomy Devices, Other Products 2) By Application: Peripheral Vascular, Cardiovascular, Coronary Artery Disease 3) By End User: Hospitals And Surgical Centers, Ambulatory Care Centers, Cardiac Specialty Centers Subsegments: 1) By Directional Atherectomy Devices: Traditional Directional Atherectomy Devices, Advanced Directional Atherectomy Devices 2) By Orbital Atherectomy Devices: Single-Wire Orbital Atherectomy Devices, Multi-Wire Orbital Atherectomy Devices 3) By Photo-Ablative Atherectomy Devices: Laser-Based Photo-Ablative Devices, Other Photo-Ablative Atherectomy Devices 4) By Rotational Atherectomy Devices: Manual Rotational Atherectomy Devices, Motorized Rotational Atherectomy Devices 5) By Other Products: Combination Atherectomy Devices, Custom Atherectomy Solutions, Other Coronary Atherectomy Devices

What Is The Driver Of The Coronary Atherectomy Devices Market?

The increasing prevalence of cardiovascular diseases (CVDs) is driving the growth of the coronary atherectomy devices market going forward. Cardiovascular diseases refer to a group of disorders affecting the heart and blood vessels, often caused by plaque buildup, restricted blood flow, and progressive arterial narrowing. The rising burden of cardiovascular diseases is due to increasing prevalence of modifiable risk factors such as hypertension, obesity, diabetes, unhealthy diets, physical inactivity, and tobacco use. This growing disease prevalence supports the coronary atherectomy devices by increasing the need for minimally invasive tools that can effectively remove calcified or complex plaque, restore optimal blood flow, and improve procedural success rates in percutaneous coronary interventions (PCI). For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based public health institute, in 2023, about 1 out of every 6 deaths from cardiovascular diseases was among adults younger than 65 years old, and a total of 919,032 people died from cardiovascular disease, representing 1 in every 3 deaths. Therefore, increasing the prevalence of cardiovascular diseases is driving the growth of the global coronary atherectomy devices industry.

Key Players In The Global Coronary Atherectomy Devices Market

Major companies operating in the coronary atherectomy devices market are Boston Scientific Corporation, Cardiovascular Systems Inc., The Spectranetics Corporation, Medtronic Inc., Avinger Inc., Biotronik SE & Co. KG, Arterial Remodeling Technologies, Straub Medical AG, RA Medical Systems Inc., Shockwave Medical Inc., Terumo Corporation, Abbott Laboratories Inc., Asahi Intecc Co. Ltd., Baylis Medical Company Inc., Cook Medical LLC, Cordis Corporation, Infraredx Inc., Intact Vascular Inc., TriReme Medical LLC, Volcano Corporation

Global Coronary Atherectomy Devices Market Trends and Insights

Major companies operating in the coronary atherectomy equipment market are focusing on innovative solutions, such as radial access catheters, to improve patient outcomes by enabling safer and less invasive procedures for the treatment of coronary artery disease. Radial Access Catheters refer to specialized medical devices used in interventional cardiology to access the coronary arteries through the radial artery in the wrist rather than the traditional femoral artery in the groin. For instance, in January 2024, AngioDynamics, a US-based provider of products and solutions to healthcare professionals, announced FDA 510(k) clearance for its Auryon XL Radial Access Catheter, designed to treat peripheral arterial disease (PAD). This 225-cm catheter, compatible with the Auryon Atherectomy System, offers two diameter options (0.9 mm and 1.5 mm) and utilizes advanced laser technology for effective treatment of arterial occlusions. Notably, radial access significantly reduces major bleeding risks compared to traditional femoral access and allows for bilateral disease treatment in a single session, promoting faster recovery.

What Are Latest Mergers And Acquisitions In The Coronary Atherectomy Devices Market?

In April 2023, Abbott Laboratories, a US-based medical device company, acquired Cardiovascular Systems, Inc. for an amount of $890 million. With this acquisition, Abbott is going to more effectively treat patients with peripheral and coronary artery disease by prepping the arteries for angioplasty or stenting procedures to restore blood flow. Cardiovascular Systems, Inc. is a US-based medical device company focused on producing cutting-edge treatments for coronary artery disease and complicated peripheral vascular disease.

Regional Outlook

North America was the largest region in the coronary atherectomy devices market in 2025. Western Europe was the second-largest region in the global coronary atherectomy devices market share. Africa, was the smallest region in the coronary atherectomy devices industry. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

What Defines the Coronary Atherectomy Devices Market?

The coronary atherectomy devices market consists of sales of directional atherectomy devices, orbital atherectomy devices, photo-ablative atherectomy devices, rotational atherectomy devices, and others that are used to treat coronary atherectomy. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.